Related references
Note: Only part of the references are listed.Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007
I. Baldi et al.
NEURO-ONCOLOGY (2011)
Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004
Luc Bauchet et al.
NEURO-ONCOLOGY (2010)
Long-term use of temozolomide: Could you use temozolomide safely for life in gliomas?
Mustafa Khasraw et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2009)
New (alternative) temozolomide regimens for the treatment of glioma
Wolfgang Wick et al.
NEURO-ONCOLOGY (2009)
Operative Techniques for Gliomas and the Value of Extent of Resection
Nader Sanai et al.
NEUROTHERAPEUTICS (2009)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cancer incidence and mortality in France over the period 1980-2005
A. Belot et al.
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE (2008)
Therapeutic strategies for the management of gliomas
A. F. Hottinger et al.
REVUE NEUROLOGIQUE (2008)
Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma
Antje Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
French brain tumor data bank: Methodology and first results on 10,000 cases
Luc Bauchet et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Reimbursement for cancer treatment: Coverage of off-label drug indications
JOURNAL OF CLINICAL ONCOLOGY (2006)
Progressive low-grade oligodendrogliomas -: Response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression
N Levin et al.
CANCER (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: A phase II randomized trial
E Verger et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions
K Hoang-Xuan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas
M Brada et al.
ANNALS OF ONCOLOGY (2003)
Audit of compliance to adjuvant chemotherapy and radiotherapy guidelines in breast cancer in a cancer network
SP Balasubramanian et al.
BREAST (2003)
Phase II trial of temozolomide in patients with progressive low-grade glioma
JA Quinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response
A Pace et al.
ANNALS OF ONCOLOGY (2003)
Phase II Randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases
D Antonadou et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
WKA Yung et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
